このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

TCI バランスシートの健全性

財務の健全性基準チェック /56

TCIの総株主資本はNT$10.1B 、総負債はNT$1.6Bで、負債比率は15.9%となります。総資産と総負債はそれぞれNT$14.7BとNT$4.6Bです。 TCIの EBIT はNT$977.5Mで、利息カバレッジ比率-14.4です。現金および短期投資はNT$6.4Bです。

主要情報

15.9%

負債資本比率

NT$1.60b

負債

インタレスト・カバレッジ・レシオ	-14.4x
現金	NT$6.37b
エクイティ	NT$10.09b
負債合計	NT$4.63b
総資産	NT$14.72b

財務の健全性に関する最新情報

We Think TCI (GTSM:8436) Can Stay On Top Of Its Debt

Jan 21

Recent updates

財務状況分析

短期負債: 8436の短期資産 ( NT$8.5B ) が短期負債 ( NT$3.6B ) を超えています。

長期負債: 8436の短期資産 ( NT$8.5B ) が長期負債 ( NT$1.0B ) を上回っています。

デット・ツー・エクイティの歴史と分析

負債レベル: 8436総負債よりも多くの現金を保有しています。

負債の削減: 8436の負債対資本比率は、過去 5 年間で6.8%から15.9%に増加しました。

債務返済能力: 8436の負債は営業キャッシュフローによって十分にカバーされています ( 141.6% )。

インタレストカバレッジ: 8436支払う利息よりも稼ぐ利息の方が多いので、利息支払いの補償は問題になりません。

TCI バランスシートの健全性

財務の健全性 基準チェック /56

主要情報

財務の健全性に関する最新情報

We Think TCI (GTSM:8436) Can Stay On Top Of Its Debt

Recent updates

New major risk - Revenue and earnings growth

TCI Co., Ltd. Approves the By-Election of Ching-Ting Chen as Institutional Director

Consensus EPS estimates increase by 16%

First quarter 2024 earnings: EPS exceeds analyst expectations

Now 21% overvalued

TCI Co., Ltd. Board Approves Dividend Distribution for the Year Ended December 31, 2023

TCI Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

TCI Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

Consensus revenue estimates fall by 12%

Full year 2023 earnings: EPS and revenues miss analyst expectations

TCI Co., Ltd., Annual General Meeting, Jun 25, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

TCI Co., Ltd. Unveils Weight Loss Formula at SupplySide West 2023

Upcoming dividend of NT$5.02 per share at 4.8% yield

TCI Co., Ltd. Announces Cash Dividend, Payable on August 22, 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

TCI Introduces Vecollal

TCI Introduces Vecollal

Insufficient new directors

TCI Co., Ltd. Appoints Representative of the Legal Person as Director

Consensus EPS estimates fall by 26%

TCI Co., Ltd. Announces Cash Dividend for the Year Ended December 31, 2022

Now 22% undervalued

Now 20% undervalued

Price target increased by 11% to NT$179

Consensus forecasts updated

Price target increased to NT$177

Investor sentiment improved over the past week

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

TCI Co., Ltd. Announces Executive Changes

Consensus EPS estimates fall by 31%

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of NT$8.92 per share

TCI Co., Ltd. Approves Cash Dividend, Payable on August 18, 2022

Price target decreased to NT$183

TCI Co., Ltd. Appoints Members of the Risk Management Committee

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Price target decreased to NT$197

TCI Co., Ltd., Annual General Meeting, Jun 29, 2022

Price target decreased to NT$197

Consensus EPS estimates fall by 13%

Price target decreased to NT$258

Price target decreased to NT$278

Price target decreased to NT$283

Third quarter 2021 earnings released: EPS NT$4.02 (vs NT$4.23 in 3Q 2020)

Upcoming dividend of NT$8.88 per share

Second quarter 2021 earnings released: EPS NT$4.19 (vs NT$4.50 in 2Q 2020)

Investor sentiment improved over the past week

TCI Co., Ltd. (TPEX:8436) entered into a memorandum of understanding to acquire US manufacturing operations from NewAge, Inc. (NasdaqCM:NBEV) for $3.5 million.

Head of Finance Department & CFO Chia- Chi Li has left the company

Price target increased to NT$249

Price target increased to NT$240

First quarter 2021 earnings released: EPS NT$3.25 (vs NT$3.13 in 1Q 2020)

Is TCI Co., Ltd. (GTSM:8436) A Smart Choice For Dividend Investors?

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$15.69 (vs NT$17.02 in FY 2019)

Analysts lower EPS estimates to NT$15.17

TCI Co., Ltd. (GTSM:8436) made an offer to acquire 30% stake in Maxigen Biotech Inc. (TSEC:1783) for approximately TWD 600 million.

Price target lowered to NT$235

Full year 2020 earnings released: EPS NT$15.69 (vs NT$17.02 in FY 2019)

Revenue and earnings miss expectations

New 90-day high: NT$221

Is TCI's (GTSM:8436) 160% Share Price Increase Well Justified?

We Think TCI (GTSM:8436) Can Stay On Top Of Its Debt

New 90-day low: NT$197

Is TCI (GTSM:8436) The Next Multi-Bagger?

New 90-day low: NT$209

Did You Participate In Any Of TCI's (GTSM:8436) Incredible 308% Return?

Price target lowered to NT$270

New 90-day low: NT$222

Third quarter earnings released

Third-quarter earnings released: Revenue and earnings miss expectations

財務の健全性基準チェック /56